ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
PGHD and How It Is Managed
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 270511" data-attributes="member: 13851"><p>[MEDIA=youtube]AXZ6WmX7wp0[/MEDIA]</p><p></p><p><em><strong>The video discusses pediatric growth hormone deficiency (PGHD) and its management, particularly through daily or weekly growth hormone injections. It explains the diagnosis process, the two categories of patients (moderate and severe), and the different treatment options available, including a unique growth hormone secretagogue drug that works to restore natural production of growth hormone.</strong></em></p><p></p><p></p><p><strong>Highlights:</strong></p><p></p><ul> <li data-xf-list-type="ul"><em><em>Most PGHD patients have a mild to moderate form of the disease, with some having a severe form.</em></em></li> <li data-xf-list-type="ul"><em><em>Standard care involves daily growth hormone injections for seven to eight years, but weekly injection options are available.</em></em></li> <li data-xf-list-type="ul"><em><em>Diagnosis involves monitoring growth patterns and referral to a pediatric endocrinologist for testing.</em></em></li> <li data-xf-list-type="ul"><em><em>Patients are categorized as moderate or severe based on their pituitary axis function and potential causes of their condition.</em></em></li> <li data-xf-list-type="ul"><em><em>Severe cases may be caused by head trauma, radiation, genetic factors, or unknown causes.</em></em></li> <li data-xf-list-type="ul"><em><em>Recombinant growth hormone and a growth hormone secretagogue drug are treatment options for PGHD.</em></em></li> <li data-xf-list-type="ul"><em><em>The growth hormone secretagogue drug stimulates the pituitary to produce more growth hormone in a natural way.</em></em></li> <li data-xf-list-type="ul"><em><em>The drug aims to restore patients to their own natural production of growth hormone, unlike exogenous injectable products.</em></em></li> <li data-xf-list-type="ul"><em><em>Injectable growth hormone products can lead to high levels of a growth factor called igf-1, while the secretagogue drug aims to maintain natural levels.</em></em></li> <li data-xf-list-type="ul"><em><em>It will take time to fully understand the effects of long-acting growth hormone products, while the drug aims to work within the natural physiology to avoid high levels of igf-1.</em></em></li> </ul></blockquote><p></p>
[QUOTE="madman, post: 270511, member: 13851"] [MEDIA=youtube]AXZ6WmX7wp0[/MEDIA] [I][B]The video discusses pediatric growth hormone deficiency (PGHD) and its management, particularly through daily or weekly growth hormone injections. It explains the diagnosis process, the two categories of patients (moderate and severe), and the different treatment options available, including a unique growth hormone secretagogue drug that works to restore natural production of growth hormone.[/B][/I] [B]Highlights:[/B] [LIST] [*][I][I]Most PGHD patients have a mild to moderate form of the disease, with some having a severe form.[/I][/I] [*][I][I]Standard care involves daily growth hormone injections for seven to eight years, but weekly injection options are available.[/I][/I] [*][I][I]Diagnosis involves monitoring growth patterns and referral to a pediatric endocrinologist for testing.[/I][/I] [*][I][I]Patients are categorized as moderate or severe based on their pituitary axis function and potential causes of their condition.[/I][/I] [*][I][I]Severe cases may be caused by head trauma, radiation, genetic factors, or unknown causes.[/I][/I] [*][I][I]Recombinant growth hormone and a growth hormone secretagogue drug are treatment options for PGHD.[/I][/I] [*][I][I]The growth hormone secretagogue drug stimulates the pituitary to produce more growth hormone in a natural way.[/I][/I] [*][I][I]The drug aims to restore patients to their own natural production of growth hormone, unlike exogenous injectable products.[/I][/I] [*][I][I]Injectable growth hormone products can lead to high levels of a growth factor called igf-1, while the secretagogue drug aims to maintain natural levels.[/I][/I] [*][I][I]It will take time to fully understand the effects of long-acting growth hormone products, while the drug aims to work within the natural physiology to avoid high levels of igf-1.[/I][/I] [/LIST] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
PGHD and How It Is Managed
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top